strategies for approaching frontline therapy in egfr nsclc
Published 4 years ago • 63 plays • Length 8:00Download video MP4
Download video MP3
Similar videos
-
9:49
osimertinib as frontline therapy for egfr-positive nsclc
-
8:11
advances in frontline therapy for egfr nsclc
-
6:51
osimertinib as frontline therapy in egfr-positive nsclc
-
9:31
frontline treatment for egfr nsclc
-
5:18
frontline therapy for egfr plus nsclc: osimertinib’s impact
-
23:10
egfr mutation positive tumors: treatment strategies in front line and at relapse
-
2:23
therapeutic strategies for egfr-mutated lung cancer
-
1:23
dr. kujtan on frontline therapy for egfr-positive nsclc
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
5:00
options for up-front therapy in egfr-mutant nsclc
-
18:06
egfr inhibitors in mutation ( ) patients: current therapeutic strategies in the frontline setting
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
20:24
targeted treatment with egfr tkis: front line options
-
4:37
frontline therapy approaches for small cell lung cancer
-
5:47
egfr tkis for upfront treatment of nsclc
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
10:06
debate: what is the optimal timing for egfr-targeted therapy? - favor frontline therapy
-
6:51
progression in alk nsclc after frontline therapy